|Min SIP Amount||Not Supported|
|NAV||₹11.55 (24 Nov 2020)|
|Fund Started||08 Dec 2017|
|Fund Size||₹640 Cr|
|ICICI Bank Ltd.||Financial||Equity||7.3%|
|Multi Commodity Exchange India||Financial||Equity||6.8%|
|Bharti Airtel Ltd.||Communication||Equity||6.3%|
|Crompton Greaves Consumer Electricals Ltd.||Cons Durable||Equity||6.0%|
|Torrent Pharmaceuticals Ltd.||Healthcare||Equity||5.5%|
|Ipca Laboratories Ltd.||Healthcare||Equity||5.5%|
|Axis Bank Ltd.||Financial||Equity||5.1%|
|Eicher Motors Ltd.||Automobile||Equity||4.6%|
UTI Focussed Equity Fund Series V (1102 Days) Direct Growth is a Equity Mutual Fund Scheme launched by Axis Mutual Fund. This scheme was made available to investors on 08 Dec 2017. Vetri Subramaniam, Sachin Trivedi is the Current Fund Manager of UTI Focussed Equity Fund Series V (1102 Days) Direct Growth fund.The fund currently has an Asset Under Management(AUM) of ₹640 Cr and the Latest NAV as of 24 Nov 2020 is ₹11.55.
The UTI Focussed Equity Fund Series V (1102 Days) Direct Growth is rated Moderately High risk. Minimum SIP Investment is set to 500.
The scheme seeks to generate long term capital appreciation by investing predominantly in equity and equity related securities of listed companies. The scheme will without any capitalization bias endeavour to invest in either growth stocks or value stocks or both. The Scheme will normally hold upto 30 stocks in the portfolio.